| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 23 Jan 2026 | 19 Jan 2026 |
| Quarterly Results Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 ,inter alia, to consider and approve Approval of unaudited financial results of the Company for the quarter ended December 31, 2025. Outcome of the Board meeting approving the unaudited financial results for the quarter ended December 31, 2025 (As Per BSE Announcement Dated on:23.01.2026) | ||
| Board Meeting | 11 Nov 2025 | 5 Nov 2025 |
| Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve the financial results for the quarter and half year ended September 30 2025. Outcome of the Board Meeting held on 11/11/2025 to approve the financial results for the quarter and half year ended September 30, 2025. Financial Results for the quarter and half year ended September 30, 2025 (As Per BSE Announcement Dated on:11.11.2025) | ||
| Board Meeting | 4 Aug 2025 | 29 Jul 2025 |
| Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 inter alia to consider and approve the standalone and consolidated financial results for the quarter ended June 30 2025 The Board has approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (As Per BSE Announcement Dated on :04.08.2025) | ||
| Board Meeting | 5 May 2025 | 29 Apr 2025 |
| Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2025 inter alia to consider and approve Intimation of Board meeting dated 05.05.2025 at 15:45 hrs for approval of audited financial results for the quarter and year ended March 312025 Outcome of the Board meeting held on May 05,2025 (As Per Bse Announcement Dated on :05.05.2025) General Updates (As per BSE Announcement Dated on 15/07/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
